Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
Strongbridge Urges Shareholders to Vote FOR All Transaction-Related Proposals
DUBLIN, Ireland and TREVOSE, Pa., Aug. 30, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (Nasdaq: SBBP) (Strongbridge) today announced that the leading independent proxy…
